vs
Antero Midstream Corp（AM）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Antero Midstream Corp的季度营收约是Orthofix Medical Inc.的1.3倍（$291.1M vs $219.9M），Antero Midstream Corp净利率更高（41.5% vs -1.0%，领先42.5%），Orthofix Medical Inc.同比增速更快（2.0% vs -7.3%），Antero Midstream Corp自由现金流更多（$186.9M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 3.9%）
Antero Midstream Corp是美国能源企业，注册地为特拉华州，总部设于科罗拉多州丹佛市。公司全部油气储量均位于阿巴拉契亚盆地，采用水力压裂技术开采，核心业务涵盖油气勘探开发相关领域。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
AM vs OFIX — 直观对比
营收规模更大
AM
是对方的1.3倍
$219.9M
营收增速更快
OFIX
高出9.3%
-7.3%
净利率更高
AM
高出42.5%
-1.0%
自由现金流更多
AM
多$170.1M
$16.8M
两年增速更快
OFIX
近两年复合增速
3.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $291.1M | $219.9M |
| 净利润 | $120.7M | $-2.2M |
| 毛利率 | — | 71.1% |
| 营业利润率 | 60.9% | 0.2% |
| 净利率 | 41.5% | -1.0% |
| 营收同比 | -7.3% | 2.0% |
| 净利润同比 | 2.1% | 92.4% |
| 每股收益（稀释后） | $0.25 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMOFIX
| Q1 26 | $291.1M | — | ||
| Q4 25 | $297.0M | $219.9M | ||
| Q3 25 | $294.8M | $205.6M | ||
| Q2 25 | $305.5M | $203.1M | ||
| Q1 25 | $291.1M | $193.6M | ||
| Q4 24 | $287.5M | $215.7M | ||
| Q3 24 | $269.9M | $196.6M | ||
| Q2 24 | $269.8M | $198.6M |
净利润AMOFIX
| Q1 26 | $120.7M | — | ||
| Q4 25 | $51.9M | $-2.2M | ||
| Q3 25 | $116.0M | $-22.8M | ||
| Q2 25 | $124.5M | $-14.1M | ||
| Q1 25 | $120.7M | $-53.1M | ||
| Q4 24 | $111.2M | $-29.1M | ||
| Q3 24 | $99.7M | $-27.4M | ||
| Q2 24 | $86.0M | $-33.4M |
毛利率AMOFIX
| Q1 26 | — | — | ||
| Q4 25 | — | 71.1% | ||
| Q3 25 | — | 72.2% | ||
| Q2 25 | — | 68.7% | ||
| Q1 25 | — | 62.8% | ||
| Q4 24 | — | 69.0% | ||
| Q3 24 | — | 68.7% | ||
| Q2 24 | — | 67.8% |
营业利润率AMOFIX
| Q1 26 | 60.9% | — | ||
| Q4 25 | 33.8% | 0.2% | ||
| Q3 25 | 61.2% | -8.3% | ||
| Q2 25 | 61.0% | -7.9% | ||
| Q1 25 | 60.9% | -25.2% | ||
| Q4 24 | 61.8% | -5.3% | ||
| Q3 24 | 60.2% | -9.6% | ||
| Q2 24 | 56.6% | -12.5% |
净利率AMOFIX
| Q1 26 | 41.5% | — | ||
| Q4 25 | 17.5% | -1.0% | ||
| Q3 25 | 39.3% | -11.1% | ||
| Q2 25 | 40.8% | -6.9% | ||
| Q1 25 | 41.5% | -27.4% | ||
| Q4 24 | 38.7% | -13.5% | ||
| Q3 24 | 37.0% | -13.9% | ||
| Q2 24 | 31.9% | -16.8% |
每股收益（稀释后）AMOFIX
| Q1 26 | $0.25 | — | ||
| Q4 25 | $0.11 | $-0.05 | ||
| Q3 25 | $0.24 | $-0.57 | ||
| Q2 25 | $0.26 | $-0.36 | ||
| Q1 25 | $0.25 | $-1.35 | ||
| Q4 24 | $0.23 | $-0.76 | ||
| Q3 24 | $0.21 | $-0.71 | ||
| Q2 24 | $0.18 | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.4M | $82.0M |
| 总债务越低越好 | $3.2B | — |
| 股东权益账面价值 | $2.0B | $450.0M |
| 总资产 | $5.9B | $850.6M |
| 负债/权益比越低杠杆越低 | 1.63× | — |
8季度趋势，按日历期对齐
现金及短期投资AMOFIX
| Q1 26 | $180.4M | — | ||
| Q4 25 | $180.4M | $82.0M | ||
| Q3 25 | — | $62.9M | ||
| Q2 25 | — | $65.6M | ||
| Q1 25 | — | $58.0M | ||
| Q4 24 | — | $83.2M | ||
| Q3 24 | — | $30.1M | ||
| Q2 24 | — | $26.4M |
总债务AMOFIX
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.0B | $157.2M | ||
| Q2 25 | $3.0B | $157.0M | ||
| Q1 25 | $3.1B | $156.9M | ||
| Q4 24 | $3.1B | $157.0M | ||
| Q3 24 | $3.2B | $118.5M | ||
| Q2 24 | $3.2B | $118.0M |
股东权益AMOFIX
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $450.0M | ||
| Q3 25 | $2.1B | $442.5M | ||
| Q2 25 | $2.1B | $458.3M | ||
| Q1 25 | $2.1B | $458.3M | ||
| Q4 24 | $2.1B | $503.1M | ||
| Q3 24 | $2.1B | $525.9M | ||
| Q2 24 | $2.1B | $546.0M |
总资产AMOFIX
| Q1 26 | $5.9B | — | ||
| Q4 25 | $5.9B | $850.6M | ||
| Q3 25 | $5.7B | $832.6M | ||
| Q2 25 | $5.7B | $837.2M | ||
| Q1 25 | $5.8B | $823.1M | ||
| Q4 24 | $5.8B | $893.3M | ||
| Q3 24 | $5.8B | $867.9M | ||
| Q2 24 | $5.8B | $882.0M |
负债/权益比AMOFIX
| Q1 26 | 1.63× | — | ||
| Q4 25 | 1.63× | — | ||
| Q3 25 | 1.46× | 0.36× | ||
| Q2 25 | 1.45× | 0.34× | ||
| Q1 25 | 1.49× | 0.34× | ||
| Q4 24 | 1.47× | 0.31× | ||
| Q3 24 | 1.49× | 0.23× | ||
| Q2 24 | 1.50× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $186.9M | $16.8M |
| 自由现金流率自由现金流/营收 | 64.2% | 7.6% |
| 资本支出强度资本支出/营收 | 11.1% | 4.9% |
| 现金转化率经营现金流/净利润 | 1.65× | — |
| 过去12个月自由现金流最近4个季度 | — | $-1.3M |
8季度趋势，按日历期对齐
经营现金流AMOFIX
| Q1 26 | $198.9M | — | ||
| Q4 25 | $255.5M | $27.7M | ||
| Q3 25 | $212.8M | $12.4M | ||
| Q2 25 | $265.2M | $11.6M | ||
| Q1 25 | $198.9M | $-18.4M | ||
| Q4 24 | $232.7M | $23.7M | ||
| Q3 24 | $184.9M | $11.7M | ||
| Q2 24 | $215.8M | $9.0M |
自由现金流AMOFIX
| Q1 26 | $186.9M | — | ||
| Q4 25 | — | $16.8M | ||
| Q3 25 | — | $2.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $-25.1M | ||
| Q4 24 | — | $15.2M | ||
| Q3 24 | $184.3M | $6.3M | ||
| Q2 24 | $147.2M | $-360.0K |
自由现金流率AMOFIX
| Q1 26 | 64.2% | — | ||
| Q4 25 | — | 7.6% | ||
| Q3 25 | — | 1.2% | ||
| Q2 25 | — | 2.2% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | 68.3% | 3.2% | ||
| Q2 24 | 54.6% | -0.2% |
资本支出强度AMOFIX
| Q1 26 | 11.1% | — | ||
| Q4 25 | — | 4.9% | ||
| Q3 25 | — | 4.8% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | 0.0% | 4.0% | ||
| Q3 24 | 0.2% | 2.7% | ||
| Q2 24 | 25.4% | 4.7% |
现金转化率AMOFIX
| Q1 26 | 1.65× | — | ||
| Q4 25 | 4.92× | — | ||
| Q3 25 | 1.84× | — | ||
| Q2 25 | 2.13× | — | ||
| Q1 25 | 1.65× | — | ||
| Q4 24 | 2.09× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 2.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AM
| Gathering and compression–Antero Resources | $238.0M | 82% |
| Other | $52.3M | 18% |
| Water handling–third party | $505.0K | 0% |
| Gathering and compression–third party | $295.0K | 0% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
